- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05098314
Impact of Personalized Interventions to Raise Teleconsultation Awareness in EHPAD
Impact of Personalized Interventions to Raise Teleconsultation Awareness: The Case of the Cicat-Occitanie Network and Healthcare Professionals in Lozère's EHPADs
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34295
- Uhmontpellier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- Be a resident in Lozère's EHPAD
Exclusion Criteria:
- Patient who reject the study protocol
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
EHPAD with personalized interventions
EHPAD with personalized interventions.
|
First of all, healthcare professionals from EHPAD in the intervention arm were invited by email to answer a closed questionnaire. It was built by the authors, on Google forms, and consisted of 11 questions divided into 2 sections. Section 1 collected data about the participants. In section 2, they were asked to score from 0 to 4 (ranging from "not at all "to" a lot ") the various obstacles to teleconsultations reported by the literature. |
EHPAD without personalized interventions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Requests rate for teleconsultations
Time Frame: 3 months
|
Requests rate for teleconsultations with the Cicat-Occitanie network by Lozère's EHAPDs. Incidence in resident-year of new requests of teleconsultations from the Cicat-Occitanie network by health professionals from Lozère's EHPADs. Calculated via numbers transmitted by the Cicat-Occitanie network 3 months after the intervention and the number of residents in each EHPAD. |
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Human obstacles linked to the use of teleconsultations
Time Frame: 4 months
|
Human obstacles linked to the use of teleconsultations with the Cicat-Occitanie network reported by health professionals in Lozère's EHPAD Rating of the different human obstacles from 0 to 4 (not at all to a lot) by the health professionals in EHPAD of Lozère.
This was collected through an online questionnaire.
|
4 months
|
Organizational obstacles linked to the use of teleconsultations
Time Frame: 4 months
|
Organizational obstacles linked to the use of teleconsultations from the Cicat-Occitanie network reported by health professionals in Lozère's EHPAD. Rating of the different organizational obstacles from 0 to 4 (not at all to a lot) by the health professionals in EHPAD of Lozère. This was collected through an online questionnaire. |
4 months
|
Economic obstacles linked to the use of teleconsultations
Time Frame: 4 months
|
Economic obstacles linked to the use of teleconsultations from the Cicat-Occitanie network reported by health professionals in Lozère's EHPAD. Rating of the different obstacles from 0 to 4 (not at all to a lot) by the health professionals in EHPAD of Lozère. This was collected through an online questionnaire. |
4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Bastien Paul, University Hospital, Montpellier
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- RECHMPL21_0373
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Healing Disorder
-
University of Witten/HerdeckeKCI Europe Holding B.V.CompletedImpaired Wound Healing | Wound Healing Disorder | Abdominal Wound Healing Disorder | Abdominal Wound Healing Impairment | Acute Postsurgical Subcutaneous WoundBelgium, Germany
-
Nova Argentia S.r.l.RecruitingStudy to Evaluate the Effectiveness of a Medical Device Based on Hyaluronic Acid in Wounds (WOUND-H)Wound Healing DisorderItaly
-
Biointelligent Technology Systems SLUniversidad Pública de Navarra; Dasman Diabetes InstituteRecruitingWounds and Injuries | Wound Surgical | Wound Healing DisorderSpain
-
SOFAR S.p.A.CompletedWound Healing DisorderItaly
-
University of Witten/HerdeckeCologne-Merheim Medical Center (CMMC)CompletedWound Healing Disorder
-
Charite University, Berlin, GermanyUnknownMalnutrition | Wound Healing DisorderGermany
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingWound Healing | Palate; WoundBrazil
-
Stratpharma AGUniversity Hospital, GenevaCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedWound HealingUnited States
-
University Hospital, GhentCompleted
Clinical Trials on Personalized interventions regarding the Cicat-Occitanie network
-
Huazhong University of Science and TechnologyWuhan No.1 HospitalRecruitingStress, Psychological | Autonomic Nervous System Diseases | Emotional StressChina